| NK | natural killer |
| GBM | glioblastoma |
| BTZ | bortezomib |
| GM1 | monosialotetrahexosylganglioside |
| TMZ | temozolomide |
| HLA | human leucocyte antigen |
| KIR | killer immunoglobulin-like receptor |
| SHP-1/-2 | Src-Homology 2 domain Phosphatase |
| MICA/B | MHC chain-related antigen |
| ULBP | UL16-binding protein |
| TNF | tumour necrosis factor |
| IFN | interferon |
| TRAIL | TNF-related apoptosis-inducing ligand |
| DNAM-1 | DNAX accessory molecule-1 |
| ATP | adenosine triphosphate |
| IC50 | Half maximal inhibitory concentration |
| PARP-1 | poly ADP-ribose polymerase-1 |
| CQ | chloroquine |
| GFP | green fluorescent protein |
| MRI | magnetic resonance imaging |
| Mlc-1 | myeloid leukaemia cell differentiation protein |
| DMEM | Dulbecco’s Modified Eagle’s medium |
| FBS | fetal bovine serum |
| NEAA | non-essential Amino Acid |
| REK | regional committees for medical and health research ethics |
| NB | Neural Basal medium |
| PBMCs | Peripheral blood mononuclear cells |
| SC | Stem Cell Growth Medium |
| ELISA | Enzyme-linked immunosorbent assay |
| NHA | normal human astrocytes |
| E:T | effector:target |
| PBS | phosphate-buffered saline |
| IR | infrared |
| FMO | fluorescent minus one |
| DAPI | 4′,6-diamidino-2-phenylindole |
| OCR | oxygen consumption rate |
| NOD/SCID | non-obese diabetic/severe combined immunodeficiency |
| H&E | hematoxylin and eosin |
| IHC | immunohistochemistry |
| SEM | standard error of the mean |
| ANOVA | analysis of variance |
| UiB | University of Bergen |
| PI | propidium iodide |
| MFI | mean of fluorescence intensity |
| IDH | isocitrate dehydrogenase |